292 related articles for article (PubMed ID: 35530314)
1. Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies.
Nasrallah NA; Wiese BM; Sears CR
Front Oncol; 2022; 12():846965. PubMed ID: 35530314
[TBL] [Abstract][Full Text] [Related]
2. XPC beyond nucleotide excision repair and skin cancers.
Zebian A; Shaito A; Mazurier F; Rezvani HR; Zibara K
Mutat Res Rev Mutat Res; 2019; 782():108286. PubMed ID: 31843141
[TBL] [Abstract][Full Text] [Related]
3. Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress.
Melis JP; Kuiper RV; Zwart E; Robinson J; Pennings JL; van Oostrom CT; Luijten M; van Steeg H
DNA Repair (Amst); 2013 Dec; 12(12):1081-6. PubMed ID: 24084170
[TBL] [Abstract][Full Text] [Related]
4. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
5. Xeroderma Pigmentosum C (XPC) Mutations in Primary Fibroblasts Impair Base Excision Repair Pathway and Increase Oxidative DNA Damage.
Fayyad N; Kobaisi F; Beal D; Mahfouf W; Ged C; Morice-Picard F; Fayyad-Kazan M; Fayyad-Kazan H; Badran B; Rezvani HR; Rachidi W
Front Genet; 2020; 11():561687. PubMed ID: 33329698
[TBL] [Abstract][Full Text] [Related]
6. Cancer predisposition in mutant mice defective in multiple genetic pathways: uncovering important genetic interactions.
Meira LB; Reis AM; Cheo DL; Nahari D; Burns DK; Friedberg EC
Mutat Res; 2001 Jun; 477(1-2):51-8. PubMed ID: 11376686
[TBL] [Abstract][Full Text] [Related]
7. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.
Boyle J; Ueda T; Oh KS; Imoto K; Tamura D; Jagdeo J; Khan SG; Nadem C; Digiovanna JJ; Kraemer KH
Hum Mutat; 2008 Oct; 29(10):1194-208. PubMed ID: 18470933
[TBL] [Abstract][Full Text] [Related]
8. The role of XPC: implications in cancer and oxidative DNA damage.
Melis JP; Luijten M; Mullenders LH; van Steeg H
Mutat Res; 2011; 728(3):107-17. PubMed ID: 21763452
[TBL] [Abstract][Full Text] [Related]
9. Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts.
de Waard H; Sonneveld E; de Wit J; Esveldt-van Lange R; Hoeijmakers JH; Vrieling H; van der Horst GT
DNA Repair (Amst); 2008 Oct; 7(10):1659-69. PubMed ID: 18634906
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis.
He J; Zhu Q; Wani G; Sharma N; Han C; Qian J; Pentz K; Wang QE; Wani AA
J Biol Chem; 2014 Sep; 289(39):27278-27289. PubMed ID: 25118285
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma Pigmentosum C: A Valuable Tool to Decipher the Signaling Pathways in Skin Cancers.
Nasrallah A; Fayyad N; Kobaisi F; Badran B; Fayyad-Kazan H; Fayyad-Kazan M; Sève M; Rachidi W
Oxid Med Cell Longev; 2021; 2021():6689403. PubMed ID: 34630850
[TBL] [Abstract][Full Text] [Related]
12. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
13. A human XPC protein interactome--a resource.
Lubin A; Zhang L; Chen H; White VM; Gong F
Int J Mol Sci; 2013 Dec; 15(1):141-58. PubMed ID: 24366067
[TBL] [Abstract][Full Text] [Related]
14. Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer.
Naipal KA; Raams A; Bruens ST; Brandsma I; Verkaik NS; Jaspers NG; Hoeijmakers JH; van Leenders GJ; Pothof J; Kanaar R; Boormans J; van Gent DC
PLoS One; 2015; 10(4):e0126029. PubMed ID: 25927440
[TBL] [Abstract][Full Text] [Related]
15. Xeroderma pigmentosum complementation group C protein (XPC) serves as a general sensor of damaged DNA.
Shell SM; Hawkins EK; Tsai MS; Hlaing AS; Rizzo CJ; Chazin WJ
DNA Repair (Amst); 2013 Nov; 12(11):947-53. PubMed ID: 24051049
[TBL] [Abstract][Full Text] [Related]
16. Identification of four novel XPC mutations in two xeroderma pigmentosum complementation group C patients and functional study of XPC Q320X mutant.
Gu Y; Chang X; Dai S; Song Q; Zhao H; Lei P
Gene; 2017 Sep; 628():162-169. PubMed ID: 28669926
[TBL] [Abstract][Full Text] [Related]
17. Regulation of XPC deubiquitination by USP11 in repair of UV-induced DNA damage.
Shah P; Qiang L; Yang S; Soltani K; He YY
Oncotarget; 2017 Nov; 8(57):96522-96535. PubMed ID: 29228550
[TBL] [Abstract][Full Text] [Related]
18. XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.
Khan SG; Oh KS; Emmert S; Imoto K; Tamura D; Digiovanna JJ; Shahlavi T; Armstrong N; Baker CC; Neuburg M; Zalewski C; Brewer C; Wiggs E; Schiffmann R; Kraemer KH
DNA Repair (Amst); 2009 Jan; 8(1):114-25. PubMed ID: 18955168
[TBL] [Abstract][Full Text] [Related]
19. XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.
Khan SG; Yamanegi K; Zheng ZM; Boyle J; Imoto K; Oh KS; Baker CC; Gozukara E; Metin A; Kraemer KH
Hum Mutat; 2010 Feb; 31(2):167-75. PubMed ID: 19953607
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum genes and melanoma risk.
Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
